Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722239 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Drugs in Development for Bladder Cancer' returned 93 results - Page 1 of 5

 FEATURED RESULTS
Cancer Diagnostic Testing World Markets

Drug Delivery in Cancer - Technologies, Markets and Companies

Apoptosis in Oncology: Drug Pipeline Update 2008

Cancer Stem Cells: Emerging Therapeutic, Diagnostic and Mark...

Antibody Drug Target Atlas in Oncology


  Sort by   
  Sorted by Rank Top-Bottom

Bladder Cancer Drug Pipeline Update 2009  
Bioseeker, Jan 2009
... all more than 100 names Developmental stage This Drug Pipeline Update contains 73
drugs in active development for the treatment of bladder cancer: #5 marketed ...


Stakeholder Opinions: Bladder Cancer - New Drugs Needed to Challenge Ineffective 20-year Old drugs  
Datamonitor, Nov 2008, Pages: 95
... profiles 52 EOquin (apaziquone; Spectrum Pharmaceuticals) 52 Drug overview 52 Key
historical events 53 Clinical development in bladder cancer 53 Datamonitor ...


Chinese Markets for Bladder Cancer Treatment Drugs  
AMID Co., Sep 2009, Pages: 200
... Market Size Market Growth Drivers Bladder Cancer Treatment Drugs Sales Volume ... Major
Distributors Major Foreign Investment Technology Development IV. ...


European Bladder Cancer Therapeutics Markets  
Frost & Sullivan, Aug 2007, Pages: 94
... research: -Gene therapy -Cytotoxic drugs -Chemotherapy -Radiotherapy ... The failure
of several developments to improve ... of patients with bladder cancer is creating ...


Cancer Therapeutics Markets  
TriMark Publications, May 2008, Pages: 182
... 62 Table 4.7: Carcinogens in the Workplace 64 Table 5.1: Drugs Used in Bladder Cancer
Therapy 69 Table 5.2: Drugs in Development for Bladder Cancer 71 Table 5.3 ...


Bladder Cancer Therapy Area Pipeline Report  
Life Science Analytics, March 2009, Pages: 101
... provides insight into the pipeline status of bladder cancer drugs by company and
by stage as well as a summary of the latest news and developments in this area ...


Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor types  
Datamonitor, Sep 2008, Pages: 287
... events 39 Table 26: Clinical development of larotaxel in bladder cancer, 2008 40
Table 27: Fulfillment of unmet needs by pipeline bladder cancer drugs, 2008 41 ...


New Cancer Therapeutics: An Analysis Of Current And Emerging Markets  
Business Insights, Nov 2002, Pages: 252
... 3.16: Carcinogens in the workplace 100Table 4.17: Drugs used in bladder cancer therapy
111Table 4.18: Drugs in development for bladder cancer 112Table 4.19 ...


Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology and Special Focus on Breast and Prostate Cancer  
Bioseeker, Feb 2008, Pages: 450
... Drug Target Mix by Development Stage 13 Apoptopic Drug Target Mix by Cancer Indication
13.1 Basal Cell Cancer 13.2 Biliary Cancer 13.3 Bladder Cancer 13.4 Bone ...


Competitive Insights to Anti-Angiogenic Drug R&D in Oncology  
Bioseeker, March 2008, Pages: 231
... in Preclinical Development 14.6 Development Profiles of All ... Combinations 15
Anti-Angiogenic Drug Target Mix ... 15.2 Biliary Cancer 15.3 Bladder Cancer 15.4 Bone ...


Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology and Special Focus on Lung Cancer and Melanoma  
Bioseeker, Feb 2008, Pages: 540
... Drug Target Mix by Development Stage 13 Apoptopic Drug Target Mix by Cancer Indication
13.1 Basal Cell Cancer 13.2 Biliary Cancer 13.3 Bladder Cancer 13.4 Bone ...


Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Breast- and Prostate Cancer  
Bioseeker, June 2007, Pages: 380
... of Known Antibody Targets, Number of Antibody Drugs, and Highest Developmental Stage
Table ... Table 75: Antibody Pipeline by Targets in Bladder Cancer Table 76 ...


Antibody Drug Targets and Focus on Breast & Prostate Cancer  
Bioseeker, Nov 2007, Pages: 380
... of Known Antibody Targets, Number of Antibody Drugs, and Highest Developmental Stage
Table ... Table 75: Antibody Pipeline by Targets in Bladder Cancer Table 76 ...


The Drug Target Atlas of Protein Kinase Inhibitors in Oncology  
Bioseeker, Nov 2007, Pages: 300
... Stage of Drug Table 32: PKI Drug Target Mix for the Treatment of Bladder Cancer
According to the Compound Type and Developmental Stage of Drug Table 33: PKI ...


Antibody Drug Target Atlas in Oncology  
Bioseeker, June 2007, Pages: 172
... of Known Antibody Targets, Number of Antibody Drugs, and Highest Developmental Stage
Table ... Table 75: Antibody Pipeline by Targets in Bladder Cancer Table 76 ...


Drug Delivery in Cancer - Technologies, Markets and Companies  
Jain PharmaBiotech, Nov 2009, Pages: 610
... Selected antisense drugs in development for cancer ... Gene therapy for bladder cancer
Brain tumors ... implants containing anticancer drugs Biodegradable microspheres ...


Cancer Therapies - Global Strategic Business Report  
Global Industry Analysts, Inc., Feb 2009, Pages: 694
... II-37 Pancreatic Cancer II-37 Bladder Cancer II-37 ... Breakdown of Targeted Therapeutic
Drugs Under Various Stages of Development (includes corresponding ...


Building on Early Successes of Immunomodulators in the Fight Against Cancer  
Decision Resources, Inc., Sep 2007, Pages: 22
... late-stage immunomodulatory agents in development to fight ... Which drugs do the new
regulations especially ... context: observations of bladder cancer patients; the ...


Antibody Drug Targets and Special Focus on Leukemias & Lymphomas  
Bioseeker, Dec 2007, Pages: 430
... of Known Antibody Targets, Number of Antibody Drugs, and Highest Developmental Stage
Table ... Table 75: Antibody Pipeline by Targets in Bladder Cancer Table 76 ...


Orphan Drugs Pipeline Analysis: Wider Incentives Encourage Orphan Drug R&D  
Decision Resources, Inc., July 2005, Pages: 107
... indications are appropriate for orphan drug development. Indications with rapidly
expanding prevalence, such as malignant melanoma and bladder cancer, may soon ...


Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   Next -   Last


Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds